File: /home/govancoz/mail/.spam/new/1694109144.M179303P2003932.zacp120.ve.host,S=10218,W=10400
Return-Path: <theadministration@royal-orleans.com>
Delivered-To: govancoz+spam@zacp120.ve.host
Received: from zacp120.ve.host
by zacp120.ve.host with LMTP
id ON1tCdgN+mTckx4AvcbEzQ
(envelope-from <theadministration@royal-orleans.com>)
for <govancoz+spam@zacp120.ve.host>; Thu, 07 Sep 2023 19:52:24 +0200
Return-path: <theadministration@royal-orleans.com>
Envelope-to: candice@govan.co.za
Delivery-date: Thu, 07 Sep 2023 17:52:24 +0000
Received: from 7123878.royal-orleans.com ([162.240.145.82]:42700)
by zacp120.ve.host with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
(Exim 4.96)
(envelope-from <theadministration@royal-orleans.com>)
id 1qeJB0-008PHF-1O
for candice@govan.co.za;
Thu, 07 Sep 2023 17:52:24 +0000
DKIM-Signature: v=1; a=rsa-sha256; q=dns/txt; c=relaxed/relaxed;
d=royal-orleans.com; s=default; h=Reply-To:Date:From:To:Subject:MIME-Version:
Content-Type:Sender:Message-ID:Cc:Content-Transfer-Encoding:Content-ID:
Content-Description:Resent-Date:Resent-From:Resent-Sender:Resent-To:Resent-Cc
:Resent-Message-ID:In-Reply-To:References:List-Id:List-Help:List-Unsubscribe:
List-Subscribe:List-Post:List-Owner:List-Archive;
bh=DalDmogz04wlRjpjIubEM5PM3X1a39qzA3DWoR5I524=; b=arvQKxdpBtF/zAQmE+GIVm76qo
B25e6RkCgiYzFWVoY1KNwrPNGH6KjVCKDCuCRtCFOHkBLGbYfnydeUAOPch/se4ZYIZsB8+9bXoFS
KIr/zriBz5p683E0IaJuuhTQ8IPi3912sluTgDUnJ9swfHkooCIKJ83pIk08LFhD79UOn0c6bsHAW
6LEPvI0GA38HnaLnvkXrphew7z+jatfCWZBl/mdPVdHLu90rqpTVSUgfaRdEC8Rh2bja410ekM/UF
XK4n75coEQ1bKoYbiFkpZhNQCyIxZzutdQHlV6WZurnaQpKLqRlDvGxbGyr/daC/+06UDIZFhkggS
yC9i1fRw==;
Received: from ns1001864.ip-92-204-128.us ([92.204.128.76]:12357 helo=[169.254.129.240])
by 7123878.royal-orleans.com with esmtpa (Exim 4.96)
(envelope-from <theadministration@royal-orleans.com>)
id 1qdVDp-0007uA-1p;
Tue, 05 Sep 2023 06:31:58 -0600
Content-Type: multipart/alternative; boundary="===============1033626317=="
MIME-Version: 1.0
To: Recipients <theadministration@royal-orleans.com>
From: "Dr. Yasunobu Otsuga" <theadministration@royal-orleans.com>
Date: Tue, 05 Sep 2023 05:31:27 -0700
Reply-To: yasunobuotsuga1@gmail.com
X-AntiAbuse: This header was added to track abuse, please include it with any abuse report
X-AntiAbuse: Primary Hostname - 7123878.royal-orleans.com
X-AntiAbuse: Original Domain - govan.co.za
X-AntiAbuse: Originator/Caller UID/GID - [47 12] / [47 12]
X-AntiAbuse: Sender Address Domain - royal-orleans.com
X-Get-Message-Sender-Via: 7123878.royal-orleans.com: authenticated_id: theadministration@royal-orleans.com
X-Authenticated-Sender: 7123878.royal-orleans.com: theadministration@royal-orleans.com
X-Source:
X-Source-Args:
X-Source-Dir:
X-Spam-Status: Yes, score=5.0
X-Spam-Score: 50
X-Spam-Bar: +++++
X-Spam-Report: Spam detection software, running on the system "zacp120.ve.host",
has identified this incoming email as possible spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Hello Daito Pharma Co., Ltd. is a Japan-based manufacturing
pharmaceutical company engaged in the pharmaceutical ingredients and formulation
business . Are you interested in working with us to be our [...]
Content analysis details: (5.0 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
blocked. See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URIs: royal-orleans.com]
0.2 FREEMAIL_REPLYTO_END_DIGIT Reply-To freemail username ends in
digit
[yasunobuotsuga1[at]gmail.com]
0.5 SUBJ_ALL_CAPS Subject is all capitals
-0.0 SPF_PASS SPF: sender matches SPF record
0.0 HTML_MESSAGE BODY: HTML included in message
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
-0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from
envelope-from domain
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
2.0 PYZOR_CHECK Listed in Pyzor
(https://pyzor.readthedocs.io/en/latest/)
0.0 FSL_BULK_SIG Bulk signature with no Unsubscribe
2.5 FREEMAIL_FORGED_REPLYTO Freemail in Reply-To, but not From
X-Spam-Flag: YES
Subject: ***SPAM*** PROPOSED PARTNERSHIP.
You will not see this in a MIME-aware mail reader.
--===============1033626317==
Content-Type: text/plain; charset="utf-8"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
Hello =
Daito Pharma Co., Ltd. is a Japan-based manufacturing pharmaceutical comp=
any engaged in the pharmaceutical ingredients and formulation business . Ar=
e you interested in working with us to be our company representative in you=
r country, The Republic of South Africa, for a period of five years contrac=
t? Please Kindly let us know if you are interested while I direct you to m=
y working company email address =
Apologies for using my personal email address for these proposals. However=
, The reason was to get an immediate notification from you once you respond=
ed. =
Best regards,
Dr. Yasunobu Otsuga President & CEO Daito Pharmaceutical Co., Ltd. 326 Yoka=
machi, Toyama City, Toyama Prefecture 939-8567
--===============1033626317==
Content-Type: text/html; charset="utf-8"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
<HTML><head><meta http-equiv=3D"Content-Type" content=3D"text/html; charset=
=3Dutf-8"/></head><BODY><DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial,=
Helvetica, sans-serif; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSF=
ORM: none; FONT-WEIGHT: 400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPH=
ANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-l=
igatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px=
; text-decoration-thickness: initial; text-decoration-style: initial; text-=
decoration-color: initial">Hello</DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l"><BR></DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l">Daito Pharma Co., Ltd. is a Japan-based manufacturing pharmaceutic=
al company engaged in the pharmaceutical ingredients and formulation busine=
ss . Are you interested in working with us to be our company representative=
in your country, The Republic of South Africa, for a period of five years =
contract? Please Kindly let us know if you are interested while I dir=
ect you to my working company email address</DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l">
<DIV><BR></DIV>
<DIV>Apologies for using my personal email address for these proposals. How=
ever, The reason was to get an immediate notification from you once you res=
ponded.</DIV></DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l"><BR></DIV>
<DIV style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; =
WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: =
400; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTE=
R-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-v=
ariant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickn=
ess: initial; text-decoration-style: initial; text-decoration-color: initia=
l">
<DIV><SPAN style=3D"FONT-SIZE: 11pt; FONT-FAMILY: Gulim, =EA=B5=B4=EB=A6=BC=
, sans-serif; COLOR: rgb(0,0,0)">Best regards,</SPAN><BR style=3D"FON=
T-SIZE: 14px; FONT-FAMILY: Gulim, =EA=B5=B4=EB=A6=BC, sans-serif; COLOR: rg=
b(0,0,0)"><SPAN style=3D"FONT-SIZE: 11pt"><SPAN style=3D"FONT-FAMILY: Gulim=
, =EA=B5=B4=EB=A6=BC, sans-serif; COLOR: rgb(0,0,0)">Dr. </SPAN></SPAN=
>Yasunobu Otsuga</DIV>
<DIV><SPAN style=3D"FONT-SIZE: 11pt; FONT-FAMILY: Gulim, =EA=B5=B4=EB=A6=BC=
, sans-serif; COLOR: rgb(0,0,0)">President & CEO</SPAN></DIV>
<DIV>Daito Pharmaceutical Co., Ltd.</DIV>
<DIV>326 Yokamachi, Toyama City, Toyama Prefecture 939-8567</DIV></DIV></BO=
DY></HTML>
--===============1033626317==--